Investigating Hepatitis C, D and HIV Prevalance in Cases with Positive Hepatitis B Virus Antigen in a Tertiary Hospital and Examining Anti-HDV Positive Cases

Basit Öğe Kaydı
dc.contributor.authorKurt, Esma Kepenek
dc.contributor.authorBulut, Rukiyye
dc.contributor.authorKandemir, Bahar
dc.contributor.authorErayman, Ibrahim
dc.contributor.authorBitirgen, Mehmet
dc.contributor.authorTasbent, Fatma Esenkaya
dc.date.accessioned2024-02-23T14:38:23Z
dc.date.available2024-02-23T14:38:23Z
dc.date.issued2021
dc.departmentNEÜen_US
dc.description.abstractObjectives: Hepatitis B infection has a faster and more progressive course in the presence of hepatitis C virus (HCV), HDV and human immunodeficiency virus (HIV) infections. The aim of this study was to determine anti-HCV, anti-HDV and anti-HIV prevalance in hepatitis B surface antigen (HBsAg) (+) positive patients and to examine patients with positive anti-HDV. Materials and Methods: Data were obtained through scanning hepatitisB patient follow-up files and the hospital automation system. Descriptive data was expressed in numbers and percentages (%). Results: Mean age of 1829 HBsAg positive patients was 42.65 +/- 14.83 (7-95) and 1099 (60.1%) were male and 730 (39.9%) were female. 30 patients (1.64%) had anti-HCV and 28 patients (1.53%) had anti-HDV while 1 patient (0.055%) had positive anti-HIV. The mean age of the patients with positive anti-HDV was 53.16 +/- 15.46 and 12 of these (42.9%) were female and 16 (57.1%) were male. Fifteen HDV positive patients were given peginterferon and 10 patients had relapse and 4 patients had hepatocellular cancer during the follow-up. A patient died due to the quick progression of the disease after deciding upon transplantation. Conclusion: Patients should also be scanned for hepatitis C, D and HIV in the presence of hepatitis B infection and the patient should be followed up and treated accordingly if coinfection is detected.en_US
dc.identifier.doi10.4274/vhd.galenos.2020.2020.0014
dc.identifier.endpage35en_US
dc.identifier.issn1307-9441
dc.identifier.issn2147-2939
dc.identifier.issue1en_US
dc.identifier.startpage31en_US
dc.identifier.urihttps://doi.org/10.4274/vhd.galenos.2020.2020.0014
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16501
dc.identifier.volume27en_US
dc.identifier.wosWOS:000647688100006en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofViral Hepatit Dergisi-Viral Hepatitis Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHepatitis Ben_US
dc.subjectHepatitis Cen_US
dc.subjectHepatitis Den_US
dc.subjectHiven_US
dc.subjectCoinfectionen_US
dc.titleInvestigating Hepatitis C, D and HIV Prevalance in Cases with Positive Hepatitis B Virus Antigen in a Tertiary Hospital and Examining Anti-HDV Positive Casesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu